Implantable islet cells come with their own oxygen supply

(Massachusetts Institute of Technology) Researchers at MIT and a company, Beta-O2 Technologies, have designed and tested an implantable device for treatment of Type 1 diabetes. The device furnishes islet cells with their own supply of oxygen, carried in a chamber that can be replenished every 24 hours.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news